(T 13) Blood Pressure Changes With Atogepant in Overweight and Obese Persons With Migraine and Baseline Hypertension: Interim Analysis of a Phase 3, Multicenter, Open-label, 156-Week Extension Study

Presenting Author(s)

Jessica Ailani, MD

Director Medstar Georgetown Headache Center, Associate Professor Neurology
Department of Neurology, Georgetown University Hospital
Washington, DC, United States

B. Lee Peterlin, DO

Medical Director & Founder
Pennsylvania Headache Center
Camp Hill, Pennsylvania, United States
Chia-Chun Chiang, MD

Associate Professor of Neurology
Mayo Clinic
Rochester, MN, United States
Teshamae S. Monteith, MD

Professor, Clinical Neurology
University of Miami
Miami, Florida, United States
YL

Yingyi Liu, PhD

AbbVie
Chicago, Illinois, United States
EC

Eric Cohen, MD

AbbVie
Chicago, Illinois, United States
KN

Krisztian Nagy, MD, MSc

AbbVie
North Chicago, Illinois, United States
BD

Brett L. Dabruzzo, PharmD

AbbVie
Chicago, Illinois, United States
JS

Jonathan H. H. Smith, MD

AbbVie
Chicago, Illinois, United States
Dale S. Bond, PhD

Director of Research Integration
Hartford Hospital/Hartford HealthCare
Hartford, Connecticut, United States